nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Guanethidine—hypertension	0.0417	0.11	CbGbCtD
Dantrolene—CYP3A4—Hydralazine—hypertension	0.0316	0.0837	CbGbCtD
Dantrolene—CYP3A4—Guanfacine—hypertension	0.0269	0.0712	CbGbCtD
Dantrolene—CYP3A4—Isradipine—hypertension	0.0239	0.0634	CbGbCtD
Dantrolene—CYP3A4—Indapamide—hypertension	0.0211	0.0558	CbGbCtD
Dantrolene—CYP3A4—Nisoldipine—hypertension	0.0211	0.0558	CbGbCtD
Dantrolene—CYP3A4—Eplerenone—hypertension	0.0204	0.0539	CbGbCtD
Dantrolene—CYP3A4—Diltiazem—hypertension	0.0204	0.0539	CbGbCtD
Dantrolene—CYP3A4—Enalapril—hypertension	0.0181	0.0481	CbGbCtD
Dantrolene—CYP3A4—Irbesartan—hypertension	0.0166	0.044	CbGbCtD
Dantrolene—CYP3A4—Amlodipine—hypertension	0.0163	0.0431	CbGbCtD
Dantrolene—CYP3A4—Felodipine—hypertension	0.0157	0.0416	CbGbCtD
Dantrolene—CYP3A4—Nifedipine—hypertension	0.0152	0.0402	CbGbCtD
Dantrolene—CYP3A4—Carvedilol—hypertension	0.0149	0.0396	CbGbCtD
Dantrolene—CYP3A4—Nicardipine—hypertension	0.0149	0.0396	CbGbCtD
Dantrolene—CYP3A4—Propranolol—hypertension	0.0138	0.0364	CbGbCtD
Dantrolene—CYP3A4—Clonidine—hypertension	0.0131	0.0348	CbGbCtD
Dantrolene—CYP3A4—Atorvastatin—hypertension	0.0117	0.031	CbGbCtD
Dantrolene—CYP3A4—Losartan—hypertension	0.0107	0.0283	CbGbCtD
Dantrolene—CYP3A4—Verapamil—hypertension	0.00944	0.025	CbGbCtD
Dantrolene—RYR3—heart—hypertension	0.00481	0.101	CbGeAlD
Dantrolene—RYR3—smooth muscle tissue—hypertension	0.00478	0.0999	CbGeAlD
Dantrolene—RYR3—cardiovascular system—hypertension	0.00454	0.095	CbGeAlD
Dantrolene—RYR3—medulla oblongata—hypertension	0.00388	0.0812	CbGeAlD
Dantrolene—RYR3—adrenal gland—hypertension	0.00359	0.0752	CbGeAlD
Dantrolene—RYR1—heart—hypertension	0.00345	0.0722	CbGeAlD
Dantrolene—RYR1—smooth muscle tissue—hypertension	0.00343	0.0717	CbGeAlD
Dantrolene—RYR1—cardiovascular system—hypertension	0.00326	0.0682	CbGeAlD
Dantrolene—RYR3—central nervous system—hypertension	0.00281	0.0587	CbGeAlD
Dantrolene—RYR1—medulla oblongata—hypertension	0.00278	0.0582	CbGeAlD
Dantrolene—RYR1—adrenal gland—hypertension	0.00258	0.0539	CbGeAlD
Dantrolene—CYP3A4—urine—hypertension	0.00234	0.049	CbGeAlD
Dantrolene—RYR1—endocrine gland—hypertension	0.00224	0.0468	CbGeAlD
Dantrolene—RYR1—central nervous system—hypertension	0.00201	0.0421	CbGeAlD
Dantrolene—CYP3A4—kidney—hypertension	0.000554	0.0116	CbGeAlD
Dantrolene—CYP3A4—endocrine gland—hypertension	0.000389	0.00813	CbGeAlD
Dantrolene—CYP3A4—central nervous system—hypertension	0.00035	0.00732	CbGeAlD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC6A3—hypertension	0.000156	0.000671	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC2A4—hypertension	0.000152	0.000653	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ALAS1—hypertension	0.00015	0.000646	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP2J2—hypertension	0.000148	0.000638	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLG—hypertension	0.000141	0.000607	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC9A1—hypertension	0.000141	0.000604	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—hypertension	0.00014	0.0006	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4F12—hypertension	0.000139	0.000598	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CETP—hypertension	0.000139	0.000597	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP4F12—hypertension	0.000137	0.00059	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GNB3—hypertension	0.000131	0.000562	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—hypertension	0.00013	0.00056	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—AVP—hypertension	0.000129	0.000555	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B1—hypertension	0.000128	0.000551	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GNAS—hypertension	0.000127	0.000548	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP11B1—hypertension	0.000127	0.000544	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOB—hypertension	0.000125	0.000536	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLAT—hypertension	0.000122	0.000526	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2J2—hypertension	0.00012	0.000516	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2J2—hypertension	0.000118	0.000509	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ADCY5—hypertension	0.000117	0.000501	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—TPH1—hypertension	0.000116	0.000499	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC6A3—hypertension	0.000115	0.000495	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—COMT—hypertension	0.000113	0.000486	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP4F12—hypertension	0.000113	0.000484	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC2A4—hypertension	0.000112	0.000481	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—hypertension	0.000111	0.000478	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—hypertension	0.000111	0.000477	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—hypertension	0.000108	0.000463	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—hypertension	0.000107	0.000459	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PPARA—hypertension	0.000105	0.000452	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLG—hypertension	0.000104	0.000447	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B1—hypertension	0.000104	0.000447	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—hypertension	0.000103	0.000444	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4A11—hypertension	0.000101	0.000434	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP4A11—hypertension	9.97e-05	0.000428	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOA1—hypertension	9.88e-05	0.000424	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—CYP1A1—hypertension	9.8e-05	0.000421	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2J2—hypertension	9.73e-05	0.000418	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—PTGIS—hypertension	9.73e-05	0.000418	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—hypertension	9.73e-05	0.000418	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GNB3—hypertension	9.65e-05	0.000415	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—hypertension	9.61e-05	0.000413	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—hypertension	9.6e-05	0.000412	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—AVP—hypertension	9.52e-05	0.000409	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP2C18—hypertension	9.47e-05	0.000407	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GNAS—hypertension	9.4e-05	0.000404	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOB—hypertension	9.2e-05	0.000395	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—hypertension	9.1e-05	0.000391	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP1A1—hypertension	9.01e-05	0.000387	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—hypertension	8.98e-05	0.000386	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP1A1—hypertension	8.66e-05	0.000372	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ADCY5—hypertension	8.6e-05	0.00037	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—hypertension	8.59e-05	0.000369	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP4A11—hypertension	8.19e-05	0.000352	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—hypertension	8.18e-05	0.000352	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—ALDH2—hypertension	8.05e-05	0.000346	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—hypertension	7.89e-05	0.000339	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—PTGIS—hypertension	7.89e-05	0.000339	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—hypertension	7.82e-05	0.000336	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PPARA—hypertension	7.76e-05	0.000333	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—hypertension	7.66e-05	0.000329	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—hypertension	7.56e-05	0.000325	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—hypertension	7.38e-05	0.000317	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOA1—hypertension	7.28e-05	0.000313	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—hypertension	7.03e-05	0.000302	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—hypertension	6.97e-05	0.000299	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTA5—hypertension	6.62e-05	0.000285	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTA5—hypertension	6.53e-05	0.000281	CbGpPWpGaD
Dantrolene—Feeling abnormal—Furosemide—hypertension	6.53e-05	0.000191	CcSEcCtD
Dantrolene—Leukopenia—Lisinopril—hypertension	6.52e-05	0.000191	CcSEcCtD
Dantrolene—Rash—Fosinopril—hypertension	6.51e-05	0.00019	CcSEcCtD
Dantrolene—Dermatitis—Fosinopril—hypertension	6.51e-05	0.00019	CcSEcCtD
Dantrolene—Vomiting—Nifedipine—hypertension	6.48e-05	0.00019	CcSEcCtD
Dantrolene—Gastrointestinal pain—Furosemide—hypertension	6.48e-05	0.000189	CcSEcCtD
Dantrolene—Rash—Eplerenone—hypertension	6.48e-05	0.000189	CcSEcCtD
Dantrolene—Urticaria—Perindopril—hypertension	6.47e-05	0.000189	CcSEcCtD
Dantrolene—Headache—Fosinopril—hypertension	6.47e-05	0.000189	CcSEcCtD
Dantrolene—Hypersensitivity—Trandolapril—hypertension	6.47e-05	0.000189	CcSEcCtD
Dantrolene—Dermatitis—Eplerenone—hypertension	6.47e-05	0.000189	CcSEcCtD
Dantrolene—Diarrhoea—Valsartan—hypertension	6.47e-05	0.000189	CcSEcCtD
Dantrolene—Asthenia—Clonidine—hypertension	6.46e-05	0.000189	CcSEcCtD
Dantrolene—Feeling abnormal—Betaxolol—hypertension	6.46e-05	0.000189	CcSEcCtD
Dantrolene—Confusional state—Timolol—hypertension	6.46e-05	0.000189	CcSEcCtD
Dantrolene—Vomiting—Verapamil—hypertension	6.45e-05	0.000189	CcSEcCtD
Dantrolene—Urticaria—Irbesartan—hypertension	6.45e-05	0.000189	CcSEcCtD
Dantrolene—Hypersensitivity—Enalapril—hypertension	6.45e-05	0.000189	CcSEcCtD
Dantrolene—Body temperature increased—Perindopril—hypertension	6.44e-05	0.000188	CcSEcCtD
Dantrolene—Abdominal pain—Perindopril—hypertension	6.44e-05	0.000188	CcSEcCtD
Dantrolene—Diarrhoea—Olmesartan—hypertension	6.43e-05	0.000188	CcSEcCtD
Dantrolene—Headache—Eplerenone—hypertension	6.43e-05	0.000188	CcSEcCtD
Dantrolene—Rash—Nifedipine—hypertension	6.43e-05	0.000188	CcSEcCtD
Dantrolene—Dermatitis—Nifedipine—hypertension	6.42e-05	0.000188	CcSEcCtD
Dantrolene—Abdominal pain—Irbesartan—hypertension	6.42e-05	0.000188	CcSEcCtD
Dantrolene—Body temperature increased—Irbesartan—hypertension	6.42e-05	0.000188	CcSEcCtD
Dantrolene—Thrombocytopenia—Ramipril—hypertension	6.42e-05	0.000188	CcSEcCtD
Dantrolene—Anaphylactic shock—Timolol—hypertension	6.41e-05	0.000187	CcSEcCtD
Dantrolene—Rash—Verapamil—hypertension	6.4e-05	0.000187	CcSEcCtD
Dantrolene—Urticaria—Hydrochlorothiazide—hypertension	6.4e-05	0.000187	CcSEcCtD
Dantrolene—Tachycardia—Ramipril—hypertension	6.4e-05	0.000187	CcSEcCtD
Dantrolene—Dermatitis—Verapamil—hypertension	6.39e-05	0.000187	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—hypertension	6.39e-05	0.000274	CbGpPWpGaD
Dantrolene—Headache—Nifedipine—hypertension	6.39e-05	0.000187	CcSEcCtD
Dantrolene—Pruritus—Clonidine—hypertension	6.37e-05	0.000186	CcSEcCtD
Dantrolene—Body temperature increased—Hydrochlorothiazide—hypertension	6.37e-05	0.000186	CcSEcCtD
Dantrolene—Abdominal pain—Hydrochlorothiazide—hypertension	6.37e-05	0.000186	CcSEcCtD
Dantrolene—Headache—Verapamil—hypertension	6.36e-05	0.000186	CcSEcCtD
Dantrolene—Hypersensitivity—Telmisartan—hypertension	6.36e-05	0.000186	CcSEcCtD
Dantrolene—Nausea—Diltiazem—hypertension	6.34e-05	0.000186	CcSEcCtD
Dantrolene—Nausea—Indapamide—hypertension	6.34e-05	0.000186	CcSEcCtD
Dantrolene—Hyperhidrosis—Ramipril—hypertension	6.33e-05	0.000185	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—hypertension	6.31e-05	0.000271	CbGpPWpGaD
Dantrolene—Asthenia—Trandolapril—hypertension	6.3e-05	0.000184	CcSEcCtD
Dantrolene—Feeling abnormal—Losartan—hypertension	6.3e-05	0.000184	CcSEcCtD
Dantrolene—Urticaria—Furosemide—hypertension	6.29e-05	0.000184	CcSEcCtD
Dantrolene—Nausea—Carvedilol—hypertension	6.28e-05	0.000184	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTT2—hypertension	6.28e-05	0.00027	CbGpPWpGaD
Dantrolene—Asthenia—Enalapril—hypertension	6.28e-05	0.000184	CcSEcCtD
Dantrolene—Abdominal pain—Furosemide—hypertension	6.26e-05	0.000183	CcSEcCtD
Dantrolene—Body temperature increased—Furosemide—hypertension	6.26e-05	0.000183	CcSEcCtD
Dantrolene—Gastrointestinal pain—Losartan—hypertension	6.25e-05	0.000183	CcSEcCtD
Dantrolene—Dizziness—Valsartan—hypertension	6.25e-05	0.000183	CcSEcCtD
Dantrolene—Anorexia—Ramipril—hypertension	6.25e-05	0.000183	CcSEcCtD
Dantrolene—Urticaria—Betaxolol—hypertension	6.23e-05	0.000182	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—hypertension	6.22e-05	0.000267	CbGpPWpGaD
Dantrolene—Dizziness—Olmesartan—hypertension	6.22e-05	0.000182	CcSEcCtD
Dantrolene—Pruritus—Trandolapril—hypertension	6.22e-05	0.000182	CcSEcCtD
Dantrolene—Nausea—Doxazosin—hypertension	6.21e-05	0.000182	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—hypertension	6.21e-05	0.000267	CbGpPWpGaD
Dantrolene—Myalgia—Lisinopril—hypertension	6.2e-05	0.000181	CcSEcCtD
Dantrolene—Body temperature increased—Betaxolol—hypertension	6.2e-05	0.000181	CcSEcCtD
Dantrolene—Hyperhidrosis—Timolol—hypertension	6.19e-05	0.000181	CcSEcCtD
Dantrolene—Asthenia—Telmisartan—hypertension	6.19e-05	0.000181	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTT2—hypertension	6.19e-05	0.000266	CbGpPWpGaD
Dantrolene—Pruritus—Enalapril—hypertension	6.19e-05	0.000181	CcSEcCtD
Dantrolene—Diarrhoea—Clonidine—hypertension	6.16e-05	0.00018	CcSEcCtD
Dantrolene—Nausea—Fosinopril—hypertension	6.14e-05	0.000179	CcSEcCtD
Dantrolene—Discomfort—Lisinopril—hypertension	6.13e-05	0.000179	CcSEcCtD
Dantrolene—Anorexia—Timolol—hypertension	6.11e-05	0.000179	CcSEcCtD
Dantrolene—Pruritus—Telmisartan—hypertension	6.11e-05	0.000179	CcSEcCtD
Dantrolene—Nausea—Eplerenone—hypertension	6.1e-05	0.000178	CcSEcCtD
Dantrolene—Urticaria—Losartan—hypertension	6.07e-05	0.000178	CcSEcCtD
Dantrolene—Dry mouth—Lisinopril—hypertension	6.06e-05	0.000177	CcSEcCtD
Dantrolene—Nausea—Nifedipine—hypertension	6.06e-05	0.000177	CcSEcCtD
Dantrolene—Abdominal pain—Losartan—hypertension	6.04e-05	0.000177	CcSEcCtD
Dantrolene—Body temperature increased—Losartan—hypertension	6.04e-05	0.000177	CcSEcCtD
Dantrolene—Nausea—Verapamil—hypertension	6.03e-05	0.000176	CcSEcCtD
Dantrolene—Asthenia—Captopril—hypertension	6.02e-05	0.000176	CcSEcCtD
Dantrolene—Diarrhoea—Trandolapril—hypertension	6.01e-05	0.000176	CcSEcCtD
Dantrolene—Vomiting—Valsartan—hypertension	6.01e-05	0.000176	CcSEcCtD
Dantrolene—Confusional state—Lisinopril—hypertension	5.99e-05	0.000175	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CYP4F12—hypertension	5.99e-05	0.000257	CbGpPWpGaD
Dantrolene—Diarrhoea—Enalapril—hypertension	5.99e-05	0.000175	CcSEcCtD
Dantrolene—Hypersensitivity—Irbesartan—hypertension	5.98e-05	0.000175	CcSEcCtD
Dantrolene—Vomiting—Olmesartan—hypertension	5.98e-05	0.000175	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Ramipril—hypertension	5.97e-05	0.000175	CcSEcCtD
Dantrolene—Rash—Valsartan—hypertension	5.96e-05	0.000174	CcSEcCtD
Dantrolene—Dizziness—Clonidine—hypertension	5.96e-05	0.000174	CcSEcCtD
Dantrolene—Dermatitis—Valsartan—hypertension	5.95e-05	0.000174	CcSEcCtD
Dantrolene—Anaphylactic shock—Lisinopril—hypertension	5.94e-05	0.000174	CcSEcCtD
Dantrolene—Pruritus—Captopril—hypertension	5.94e-05	0.000174	CcSEcCtD
Dantrolene—Hypersensitivity—Hydrochlorothiazide—hypertension	5.93e-05	0.000174	CcSEcCtD
Dantrolene—Rash—Olmesartan—hypertension	5.93e-05	0.000173	CcSEcCtD
Dantrolene—Insomnia—Ramipril—hypertension	5.93e-05	0.000173	CcSEcCtD
Dantrolene—Dermatitis—Olmesartan—hypertension	5.92e-05	0.000173	CcSEcCtD
Dantrolene—Headache—Valsartan—hypertension	5.92e-05	0.000173	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP4F12—hypertension	5.91e-05	0.000254	CbGpPWpGaD
Dantrolene—Diarrhoea—Telmisartan—hypertension	5.9e-05	0.000173	CcSEcCtD
Dantrolene—Headache—Olmesartan—hypertension	5.89e-05	0.000172	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—hypertension	5.86e-05	0.000252	CbGpPWpGaD
Dantrolene—Asthenia—Perindopril—hypertension	5.85e-05	0.000171	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Timolol—hypertension	5.84e-05	0.000171	CcSEcCtD
Dantrolene—Hypersensitivity—Furosemide—hypertension	5.84e-05	0.000171	CcSEcCtD
Dantrolene—Asthenia—Irbesartan—hypertension	5.83e-05	0.00017	CcSEcCtD
Dantrolene—Somnolence—Ramipril—hypertension	5.83e-05	0.00017	CcSEcCtD
Dantrolene—Thrombocytopenia—Lisinopril—hypertension	5.82e-05	0.00017	CcSEcCtD
Dantrolene—Dizziness—Trandolapril—hypertension	5.81e-05	0.00017	CcSEcCtD
Dantrolene—Tachycardia—Lisinopril—hypertension	5.8e-05	0.00017	CcSEcCtD
Dantrolene—Insomnia—Timolol—hypertension	5.79e-05	0.000169	CcSEcCtD
Dantrolene—Dizziness—Enalapril—hypertension	5.79e-05	0.000169	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—hypertension	5.79e-05	0.000249	CbGpPWpGaD
Dantrolene—Asthenia—Hydrochlorothiazide—hypertension	5.78e-05	0.000169	CcSEcCtD
Dantrolene—Hypersensitivity—Betaxolol—hypertension	5.78e-05	0.000169	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—hypertension	5.77e-05	0.000248	CbGpPWpGaD
Dantrolene—Dyspepsia—Ramipril—hypertension	5.77e-05	0.000169	CcSEcCtD
Dantrolene—Pruritus—Perindopril—hypertension	5.76e-05	0.000169	CcSEcCtD
Dantrolene—Pruritus—Irbesartan—hypertension	5.75e-05	0.000168	CcSEcCtD
Dantrolene—Hyperhidrosis—Lisinopril—hypertension	5.75e-05	0.000168	CcSEcCtD
Dantrolene—Diarrhoea—Captopril—hypertension	5.74e-05	0.000168	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP19A1—hypertension	5.74e-05	0.000247	CbGpPWpGaD
Dantrolene—Vomiting—Clonidine—hypertension	5.73e-05	0.000167	CcSEcCtD
Dantrolene—Dizziness—Telmisartan—hypertension	5.71e-05	0.000167	CcSEcCtD
Dantrolene—Pruritus—Hydrochlorothiazide—hypertension	5.7e-05	0.000167	CcSEcCtD
Dantrolene—Decreased appetite—Ramipril—hypertension	5.7e-05	0.000167	CcSEcCtD
Dantrolene—Somnolence—Timolol—hypertension	5.7e-05	0.000167	CcSEcCtD
Dantrolene—Asthenia—Furosemide—hypertension	5.68e-05	0.000166	CcSEcCtD
Dantrolene—Rash—Clonidine—hypertension	5.68e-05	0.000166	CcSEcCtD
Dantrolene—Dermatitis—Clonidine—hypertension	5.67e-05	0.000166	CcSEcCtD
Dantrolene—Anorexia—Lisinopril—hypertension	5.66e-05	0.000166	CcSEcCtD
Dantrolene—Fatigue—Ramipril—hypertension	5.65e-05	0.000165	CcSEcCtD
Dantrolene—Headache—Clonidine—hypertension	5.64e-05	0.000165	CcSEcCtD
Dantrolene—Dyspepsia—Timolol—hypertension	5.64e-05	0.000165	CcSEcCtD
Dantrolene—Hypersensitivity—Losartan—hypertension	5.63e-05	0.000165	CcSEcCtD
Dantrolene—Asthenia—Betaxolol—hypertension	5.63e-05	0.000165	CcSEcCtD
Dantrolene—Nausea—Valsartan—hypertension	5.61e-05	0.000164	CcSEcCtD
Dantrolene—Pruritus—Furosemide—hypertension	5.6e-05	0.000164	CcSEcCtD
Dantrolene—Constipation—Ramipril—hypertension	5.6e-05	0.000164	CcSEcCtD
Dantrolene—Nausea—Olmesartan—hypertension	5.59e-05	0.000163	CcSEcCtD
Dantrolene—Vomiting—Trandolapril—hypertension	5.59e-05	0.000163	CcSEcCtD
Dantrolene—Diarrhoea—Perindopril—hypertension	5.57e-05	0.000163	CcSEcCtD
Dantrolene—Decreased appetite—Timolol—hypertension	5.57e-05	0.000163	CcSEcCtD
Dantrolene—Vomiting—Enalapril—hypertension	5.56e-05	0.000163	CcSEcCtD
Dantrolene—Diarrhoea—Irbesartan—hypertension	5.56e-05	0.000162	CcSEcCtD
Dantrolene—Dizziness—Captopril—hypertension	5.55e-05	0.000162	CcSEcCtD
Dantrolene—Pruritus—Betaxolol—hypertension	5.55e-05	0.000162	CcSEcCtD
Dantrolene—Rash—Trandolapril—hypertension	5.54e-05	0.000162	CcSEcCtD
Dantrolene—Dermatitis—Trandolapril—hypertension	5.53e-05	0.000162	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—AHCY—hypertension	5.53e-05	0.000237	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP11B1—hypertension	5.53e-05	0.000237	CbGpPWpGaD
Dantrolene—Fatigue—Timolol—hypertension	5.52e-05	0.000162	CcSEcCtD
Dantrolene—Rash—Enalapril—hypertension	5.52e-05	0.000161	CcSEcCtD
Dantrolene—Dermatitis—Enalapril—hypertension	5.51e-05	0.000161	CcSEcCtD
Dantrolene—Diarrhoea—Hydrochlorothiazide—hypertension	5.51e-05	0.000161	CcSEcCtD
Dantrolene—Headache—Trandolapril—hypertension	5.5e-05	0.000161	CcSEcCtD
Dantrolene—Vomiting—Telmisartan—hypertension	5.49e-05	0.00016	CcSEcCtD
Dantrolene—Asthenia—Losartan—hypertension	5.48e-05	0.00016	CcSEcCtD
Dantrolene—Headache—Enalapril—hypertension	5.48e-05	0.00016	CcSEcCtD
Dantrolene—Pain—Timolol—hypertension	5.48e-05	0.00016	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP11B1—hypertension	5.45e-05	0.000234	CbGpPWpGaD
Dantrolene—Rash—Telmisartan—hypertension	5.44e-05	0.000159	CcSEcCtD
Dantrolene—Dermatitis—Telmisartan—hypertension	5.44e-05	0.000159	CcSEcCtD
Dantrolene—Diarrhoea—Furosemide—hypertension	5.42e-05	0.000158	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Lisinopril—hypertension	5.41e-05	0.000158	CcSEcCtD
Dantrolene—Pruritus—Losartan—hypertension	5.41e-05	0.000158	CcSEcCtD
Dantrolene—Headache—Telmisartan—hypertension	5.41e-05	0.000158	CcSEcCtD
Dantrolene—Feeling abnormal—Ramipril—hypertension	5.4e-05	0.000158	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—hypertension	5.39e-05	0.000232	CbGpPWpGaD
Dantrolene—Dizziness—Perindopril—hypertension	5.39e-05	0.000158	CcSEcCtD
Dantrolene—Insomnia—Lisinopril—hypertension	5.38e-05	0.000157	CcSEcCtD
Dantrolene—Dizziness—Irbesartan—hypertension	5.37e-05	0.000157	CcSEcCtD
Dantrolene—Diarrhoea—Betaxolol—hypertension	5.37e-05	0.000157	CcSEcCtD
Dantrolene—Gastrointestinal pain—Ramipril—hypertension	5.36e-05	0.000157	CcSEcCtD
Dantrolene—Nausea—Clonidine—hypertension	5.35e-05	0.000156	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTM5—hypertension	5.34e-05	0.000229	CbGpPWpGaD
Dantrolene—Vomiting—Captopril—hypertension	5.34e-05	0.000156	CcSEcCtD
Dantrolene—Dizziness—Hydrochlorothiazide—hypertension	5.33e-05	0.000156	CcSEcCtD
Dantrolene—Rash—Captopril—hypertension	5.29e-05	0.000155	CcSEcCtD
Dantrolene—Dermatitis—Captopril—hypertension	5.29e-05	0.000155	CcSEcCtD
Dantrolene—Somnolence—Lisinopril—hypertension	5.28e-05	0.000154	CcSEcCtD
Dantrolene—Feeling abnormal—Timolol—hypertension	5.28e-05	0.000154	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—hypertension	5.28e-05	0.000227	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—EPHX1—hypertension	5.26e-05	0.000226	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM5—hypertension	5.26e-05	0.000226	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—EPHX2—hypertension	5.26e-05	0.000226	CbGpPWpGaD
Dantrolene—Headache—Captopril—hypertension	5.26e-05	0.000154	CcSEcCtD
Dantrolene—Gastrointestinal pain—Timolol—hypertension	5.24e-05	0.000153	CcSEcCtD
Dantrolene—Dizziness—Furosemide—hypertension	5.24e-05	0.000153	CcSEcCtD
Dantrolene—Dyspepsia—Lisinopril—hypertension	5.23e-05	0.000153	CcSEcCtD
Dantrolene—Diarrhoea—Losartan—hypertension	5.23e-05	0.000153	CcSEcCtD
Dantrolene—Nausea—Trandolapril—hypertension	5.22e-05	0.000153	CcSEcCtD
Dantrolene—Urticaria—Ramipril—hypertension	5.21e-05	0.000152	CcSEcCtD
Dantrolene—Nausea—Enalapril—hypertension	5.2e-05	0.000152	CcSEcCtD
Dantrolene—Dizziness—Betaxolol—hypertension	5.19e-05	0.000152	CcSEcCtD
Dantrolene—Vomiting—Perindopril—hypertension	5.18e-05	0.000151	CcSEcCtD
Dantrolene—Abdominal pain—Ramipril—hypertension	5.18e-05	0.000151	CcSEcCtD
Dantrolene—Body temperature increased—Ramipril—hypertension	5.18e-05	0.000151	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CYP2J2—hypertension	5.17e-05	0.000222	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—CAT—hypertension	5.17e-05	0.000222	CbGpPWpGaD
Dantrolene—Decreased appetite—Lisinopril—hypertension	5.17e-05	0.000151	CcSEcCtD
Dantrolene—Vomiting—Irbesartan—hypertension	5.16e-05	0.000151	CcSEcCtD
Dantrolene—Rash—Perindopril—hypertension	5.14e-05	0.00015	CcSEcCtD
Dantrolene—Dermatitis—Perindopril—hypertension	5.13e-05	0.00015	CcSEcCtD
Dantrolene—Nausea—Telmisartan—hypertension	5.13e-05	0.00015	CcSEcCtD
Dantrolene—Fatigue—Lisinopril—hypertension	5.12e-05	0.00015	CcSEcCtD
Dantrolene—Vomiting—Hydrochlorothiazide—hypertension	5.12e-05	0.00015	CcSEcCtD
Dantrolene—Rash—Irbesartan—hypertension	5.12e-05	0.00015	CcSEcCtD
Dantrolene—Dermatitis—Irbesartan—hypertension	5.12e-05	0.00015	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—hypertension	5.11e-05	0.00022	CbGpPWpGaD
Dantrolene—Headache—Perindopril—hypertension	5.1e-05	0.000149	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2J2—hypertension	5.1e-05	0.000219	CbGpPWpGaD
Dantrolene—Urticaria—Timolol—hypertension	5.09e-05	0.000149	CcSEcCtD
Dantrolene—Headache—Irbesartan—hypertension	5.09e-05	0.000149	CcSEcCtD
Dantrolene—Pain—Lisinopril—hypertension	5.08e-05	0.000149	CcSEcCtD
Dantrolene—Constipation—Lisinopril—hypertension	5.08e-05	0.000149	CcSEcCtD
Dantrolene—Rash—Hydrochlorothiazide—hypertension	5.08e-05	0.000148	CcSEcCtD
Dantrolene—Dermatitis—Hydrochlorothiazide—hypertension	5.07e-05	0.000148	CcSEcCtD
Dantrolene—Body temperature increased—Timolol—hypertension	5.06e-05	0.000148	CcSEcCtD
Dantrolene—Abdominal pain—Timolol—hypertension	5.06e-05	0.000148	CcSEcCtD
Dantrolene—Dizziness—Losartan—hypertension	5.05e-05	0.000148	CcSEcCtD
Dantrolene—Headache—Hydrochlorothiazide—hypertension	5.05e-05	0.000148	CcSEcCtD
Dantrolene—Vomiting—Furosemide—hypertension	5.04e-05	0.000147	CcSEcCtD
Dantrolene—Rash—Furosemide—hypertension	4.99e-05	0.000146	CcSEcCtD
Dantrolene—Dermatitis—Furosemide—hypertension	4.99e-05	0.000146	CcSEcCtD
Dantrolene—Vomiting—Betaxolol—hypertension	4.99e-05	0.000146	CcSEcCtD
Dantrolene—Nausea—Captopril—hypertension	4.98e-05	0.000146	CcSEcCtD
Dantrolene—Headache—Furosemide—hypertension	4.96e-05	0.000145	CcSEcCtD
Dantrolene—Rash—Betaxolol—hypertension	4.94e-05	0.000145	CcSEcCtD
Dantrolene—Dermatitis—Betaxolol—hypertension	4.94e-05	0.000144	CcSEcCtD
Dantrolene—Headache—Betaxolol—hypertension	4.91e-05	0.000144	CcSEcCtD
Dantrolene—Feeling abnormal—Lisinopril—hypertension	4.9e-05	0.000143	CcSEcCtD
Dantrolene—Gastrointestinal pain—Lisinopril—hypertension	4.86e-05	0.000142	CcSEcCtD
Dantrolene—Vomiting—Losartan—hypertension	4.86e-05	0.000142	CcSEcCtD
Dantrolene—Nausea—Perindopril—hypertension	4.84e-05	0.000142	CcSEcCtD
Dantrolene—Hypersensitivity—Ramipril—hypertension	4.83e-05	0.000141	CcSEcCtD
Dantrolene—Nausea—Irbesartan—hypertension	4.82e-05	0.000141	CcSEcCtD
Dantrolene—Rash—Losartan—hypertension	4.82e-05	0.000141	CcSEcCtD
Dantrolene—Dermatitis—Losartan—hypertension	4.81e-05	0.000141	CcSEcCtD
Dantrolene—Headache—Losartan—hypertension	4.79e-05	0.00014	CcSEcCtD
Dantrolene—Nausea—Hydrochlorothiazide—hypertension	4.78e-05	0.00014	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—hypertension	4.75e-05	0.000204	CbGpPWpGaD
Dantrolene—Urticaria—Lisinopril—hypertension	4.72e-05	0.000138	CcSEcCtD
Dantrolene—Hypersensitivity—Timolol—hypertension	4.72e-05	0.000138	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—hypertension	4.7e-05	0.000202	CbGpPWpGaD
Dantrolene—Nausea—Furosemide—hypertension	4.7e-05	0.000138	CcSEcCtD
Dantrolene—Asthenia—Ramipril—hypertension	4.7e-05	0.000137	CcSEcCtD
Dantrolene—Body temperature increased—Lisinopril—hypertension	4.7e-05	0.000137	CcSEcCtD
Dantrolene—Abdominal pain—Lisinopril—hypertension	4.7e-05	0.000137	CcSEcCtD
Dantrolene—Nausea—Betaxolol—hypertension	4.66e-05	0.000136	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—hypertension	4.64e-05	0.000199	CbGpPWpGaD
Dantrolene—Pruritus—Ramipril—hypertension	4.64e-05	0.000136	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP1A1—hypertension	4.63e-05	0.000199	CbGpPWpGaD
Dantrolene—Asthenia—Timolol—hypertension	4.6e-05	0.000134	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—hypertension	4.58e-05	0.000197	CbGpPWpGaD
Dantrolene—Nausea—Losartan—hypertension	4.54e-05	0.000133	CcSEcCtD
Dantrolene—Pruritus—Timolol—hypertension	4.53e-05	0.000133	CcSEcCtD
Dantrolene—Diarrhoea—Ramipril—hypertension	4.48e-05	0.000131	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—hypertension	4.45e-05	0.000191	CbGpPWpGaD
Dantrolene—Diarrhoea—Timolol—hypertension	4.38e-05	0.000128	CcSEcCtD
Dantrolene—Hypersensitivity—Lisinopril—hypertension	4.38e-05	0.000128	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CYP4A11—hypertension	4.35e-05	0.000187	CbGpPWpGaD
Dantrolene—Dizziness—Ramipril—hypertension	4.33e-05	0.000127	CcSEcCtD
Dantrolene—Asthenia—Lisinopril—hypertension	4.26e-05	0.000125	CcSEcCtD
Dantrolene—Dizziness—Timolol—hypertension	4.24e-05	0.000124	CcSEcCtD
Dantrolene—Pruritus—Lisinopril—hypertension	4.2e-05	0.000123	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—PTGIS—hypertension	4.19e-05	0.00018	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP3A5—hypertension	4.19e-05	0.00018	CbGpPWpGaD
Dantrolene—Vomiting—Ramipril—hypertension	4.17e-05	0.000122	CcSEcCtD
Dantrolene—Rash—Ramipril—hypertension	4.13e-05	0.000121	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP3A5—hypertension	4.13e-05	0.000177	CbGpPWpGaD
Dantrolene—Dermatitis—Ramipril—hypertension	4.13e-05	0.000121	CcSEcCtD
Dantrolene—Headache—Ramipril—hypertension	4.11e-05	0.00012	CcSEcCtD
Dantrolene—Vomiting—Timolol—hypertension	4.07e-05	0.000119	CcSEcCtD
Dantrolene—Diarrhoea—Lisinopril—hypertension	4.07e-05	0.000119	CcSEcCtD
Dantrolene—Rash—Timolol—hypertension	4.04e-05	0.000118	CcSEcCtD
Dantrolene—Dermatitis—Timolol—hypertension	4.04e-05	0.000118	CcSEcCtD
Dantrolene—Headache—Timolol—hypertension	4.01e-05	0.000117	CcSEcCtD
Dantrolene—Dizziness—Lisinopril—hypertension	3.93e-05	0.000115	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CYP11B2—hypertension	3.92e-05	0.000168	CbGpPWpGaD
Dantrolene—Nausea—Ramipril—hypertension	3.89e-05	0.000114	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP11B2—hypertension	3.86e-05	0.000166	CbGpPWpGaD
Dantrolene—Nausea—Timolol—hypertension	3.81e-05	0.000111	CcSEcCtD
Dantrolene—Vomiting—Lisinopril—hypertension	3.78e-05	0.00011	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	3.76e-05	0.000162	CbGpPWpGaD
Dantrolene—Rash—Lisinopril—hypertension	3.75e-05	0.00011	CcSEcCtD
Dantrolene—Dermatitis—Lisinopril—hypertension	3.74e-05	0.000109	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	3.74e-05	0.000161	CbGpPWpGaD
Dantrolene—Headache—Lisinopril—hypertension	3.72e-05	0.000109	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—TBXAS1—hypertension	3.7e-05	0.000159	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	3.69e-05	0.000159	CbGpPWpGaD
Dantrolene—Nausea—Lisinopril—hypertension	3.53e-05	0.000103	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—CYP2C18—hypertension	3.3e-05	0.000142	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	3.25e-05	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	3.03e-05	0.00013	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GPX3—hypertension	2.88e-05	0.000124	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—ALDH2—hypertension	2.8e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	2.79e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP11A1—hypertension	2.72e-05	0.000117	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	2.68e-05	0.000115	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTT1—hypertension	2.67e-05	0.000115	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GCLC—hypertension	2.64e-05	0.000113	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP17A1—hypertension	2.52e-05	0.000108	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—PTGS1—hypertension	2.5e-05	0.000107	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	2.49e-05	0.000107	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	2.26e-05	9.71e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP19A1—hypertension	2e-05	8.58e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	1.97e-05	8.47e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—COMT—hypertension	1.86e-05	7.98e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—COMT—hypertension	1.83e-05	7.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—hypertension	1.7e-05	7.3e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	1.68e-05	7.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP1A1—hypertension	1.61e-05	6.92e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FAH—hypertension	1.59e-05	6.83e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	1.59e-05	6.82e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HAS3—hypertension	1.2e-05	5.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HAS2—hypertension	1.2e-05	5.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HYAL2—hypertension	1.2e-05	5.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HAS1—hypertension	1.2e-05	5.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—QDPR—hypertension	1.2e-05	5.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PNMT—hypertension	1.2e-05	5.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—POMC—hypertension	1.2e-05	5.16e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTA5—hypertension	1.13e-05	4.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MDH1—hypertension	1.07e-05	4.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT2—hypertension	1.07e-05	4.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HYAL1—hypertension	1.07e-05	4.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CDO1—hypertension	1.07e-05	4.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CPS1—hypertension	1.07e-05	4.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP4F12—hypertension	1.02e-05	4.4e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCH1—hypertension	1.02e-05	4.4e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCD1—hypertension	9.82e-06	4.22e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AHCY—hypertension	9.45e-06	4.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP11B1—hypertension	9.45e-06	4.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX12—hypertension	9.13e-06	3.92e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—EPHX2—hypertension	9.13e-06	3.92e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GBA—hypertension	9.13e-06	3.92e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM5—hypertension	9.13e-06	3.92e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DBH—hypertension	9.13e-06	3.92e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2J2—hypertension	8.84e-06	3.8e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ARG1—hypertension	8.58e-06	3.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLS2—hypertension	8.58e-06	3.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DECR1—hypertension	8.58e-06	3.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COX5B—hypertension	8.58e-06	3.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALAD—hypertension	8.14e-06	3.5e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCE1—hypertension	7.76e-06	3.33e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH7A1—hypertension	7.76e-06	3.33e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STS—hypertension	7.76e-06	3.33e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP4A11—hypertension	7.44e-06	3.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ARG2—hypertension	7.44e-06	3.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CBS—hypertension	7.44e-06	3.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—XDH—hypertension	7.3e-06	3.14e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC5A2—hypertension	7.16e-06	3.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGIS—hypertension	7.16e-06	3.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP3A5—hypertension	7.16e-06	3.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TPH1—hypertension	6.92e-06	2.97e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP2—hypertension	6.92e-06	2.97e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP3—hypertension	6.92e-06	2.97e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCC1—hypertension	6.92e-06	2.97e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD11B1—hypertension	6.92e-06	2.97e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP11B2—hypertension	6.7e-06	2.88e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALAS1—hypertension	6.7e-06	2.88e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A3—hypertension	6.7e-06	2.88e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD3B1—hypertension	6.6e-06	2.84e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADA—hypertension	6.6e-06	2.84e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FADS1—hypertension	6.5e-06	2.79e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AQP1—hypertension	6.5e-06	2.79e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TBXAS1—hypertension	6.33e-06	2.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA9—hypertension	6.33e-06	2.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX15—hypertension	6.17e-06	2.65e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX5AP—hypertension	6.17e-06	2.65e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HADHA—hypertension	6.02e-06	2.59e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LHB—hypertension	6.02e-06	2.59e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD3B2—hypertension	5.88e-06	2.53e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—KCNJ11—hypertension	5.88e-06	2.53e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPA—hypertension	5.88e-06	2.53e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2C18—hypertension	5.64e-06	2.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LRP2—hypertension	5.64e-06	2.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSPG2—hypertension	5.43e-06	2.33e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX5—hypertension	5.24e-06	2.25e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLP1R—hypertension	5.24e-06	2.25e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH2—hypertension	4.8e-06	2.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HBA1—hypertension	4.67e-06	2.01e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP11A1—hypertension	4.64e-06	2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC9A1—hypertension	4.56e-06	1.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT1—hypertension	4.56e-06	1.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCLC—hypertension	4.51e-06	1.94e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CETP—hypertension	4.51e-06	1.94e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP17A1—hypertension	4.32e-06	1.86e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO1—hypertension	4.27e-06	1.84e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS1—hypertension	4.27e-06	1.84e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CTGF—hypertension	4.11e-06	1.77e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GOT2—hypertension	4.08e-06	1.75e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMGCR—hypertension	4.08e-06	1.75e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADRA2A—hypertension	3.99e-06	1.71e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TH—hypertension	3.74e-06	1.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CALM2—hypertension	3.72e-06	1.6e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCG—hypertension	3.63e-06	1.56e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A4—hypertension	3.63e-06	1.56e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GOT1—hypertension	3.52e-06	1.51e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP19A1—hypertension	3.42e-06	1.47e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STK11—hypertension	3.42e-06	1.47e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COMT—hypertension	3.18e-06	1.36e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARGC1A—hypertension	3.13e-06	1.35e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GNB3—hypertension	3.13e-06	1.35e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—hypertension	3.12e-06	1.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAT—hypertension	3.08e-06	1.32e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GNAS—hypertension	3.05e-06	1.31e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOB—hypertension	2.99e-06	1.28e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—hypertension	2.91e-06	1.25e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPL—hypertension	2.85e-06	1.23e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADCY5—hypertension	2.79e-06	1.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX1—hypertension	2.78e-06	1.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PRKCA—hypertension	2.75e-06	1.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP1A1—hypertension	2.75e-06	1.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CD36—hypertension	2.71e-06	1.16e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—hypertension	2.57e-06	1.1e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARA—hypertension	2.52e-06	1.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AGT—hypertension	2.44e-06	1.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CALM1—hypertension	2.4e-06	1.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOE—hypertension	2.39e-06	1.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAV1—hypertension	2.37e-06	1.02e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA1—hypertension	2.36e-06	1.02e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARG—hypertension	2.08e-06	8.95e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—POMC—hypertension	2.05e-06	8.82e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INS—hypertension	2.04e-06	8.77e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—hypertension	1.87e-06	8.04e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3R1—hypertension	1.79e-06	7.69e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—hypertension	1.79e-06	7.69e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—hypertension	1.64e-06	7.04e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTEN—hypertension	1.43e-06	6.14e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—EP300—hypertension	1.36e-06	5.85e-06	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—hypertension	8.23e-07	3.54e-06	CbGpPWpGaD
